Table 1 Patient characteristics stratified by the MRI radiomics signature in patients with all-stages and early-stage ENKTCL.
| Â | Â | Â | MRI radiomics signature | |||
|---|---|---|---|---|---|---|
| Â | Total | Â | Type I | Â | Type II | Â |
Characteristic | No. (%) | Â | No. (%) | Â | No. (%) | P |
All Stages (n = 176) | 176 |  | 65 |  | 111 |  |
Gender, male | 128 (72.7) | Â | 46 (70.8) | Â | 82 (73.9) | 0.655 |
Age, > 60 years | 26 (14.8) | Â | 10 (15.4) | Â | 16 (14.4) | 0.861 |
B symptoms | 82 (46.6) | Â | 22 (33.8) | Â | 60 (54.1) | 0.009 |
ECOG score ≥ 2 | 10 (5.7) |  | 1 (1.5) |  | 9 (8.1) | 0.094 |
Stage I–II | 166 (94.3) |  | 63 (96.9) |  | 103 (92.8) | < 0.001 |
PTI | 126 (71.6) |  | 23 (35.4) |  | 103 (92.8) | < 0.001 |
Elevated LDH | 46 (26.1) | Â | 9 (13.8) | Â | 37 (33.3) | 0.005 |
Primary site, nasal cavity | 141 (80.1) | Â | 58 (89.2) | Â | 83 (74.8) | 0.020 |
Stage I–II (n = 166) | 166 |  | 63 |  | 103 |  |
Gender, male | 121 (72.9) | Â | 45 (71.4) | Â | 76 (73.8) | 0.740 |
Age, > 60 years | 25 (15.1) | Â | 10 (15.9) | Â | 15 (14.6) | 0.819 |
B symptoms | 77 (46.4) | Â | 21 (33.3) | Â | 56 (54.4) | 0.008 |
ECOG score ≥ 2 | 10 (6.0) |  | 1 (1.6) |  | 9 (8.7) | 0.091 |
Stage II | 65 (39.2) |  | 3 (4.8) |  | 62 (60.2) | < 0.001 |
Elevated LDH | 43 (25.9) | Â | 9 (14.3) | Â | 34 (33.0) | 0.008 |
PTI | 116 (69.9) |  | 21 (33.3) |  | 95 (92.2) | < 0.001 |
Primary site, nasal cavity | 134 (80.7) | Â | 56 (88.9) | Â | 78 (75.7) | 0.037 |